A New Development in Early Breast Cancer Detection
Following her discovery that certain tumors appear on MRI before clinical diagnosis, Dr. Debbie Anabi began developing an AI-based technology capable of identifying these early lesions. Through a collaboration between Pinkstar and the Meirav Breast Center, this effort aims to improve early breast cancer detection.
Debbie Anabi, Head of the Breast Cancer Imaging Lab at Sheba Medical Center and CTO at Pinkstar, discovered that certain breast cancer lesions appeared on MRI before they became radiologically identifiable. Although visible within MRI resolution, these tumors were not suspected at the time. This finding motivated her to develop an AI-based technology capable of characterizing ultra-early lesions and predicting outcomes.
Implementing AI for Early Detection
Pinkstar, a company focused on developing AI technologies for breast MRI, aims to support earlier cancer detection.
Their system can successfully classify more than 65% of breast cancers one year before formal diagnosis in high-risk populations. The team highlights the complexity of breast MRI and the need for advanced tools to interpret early, subtle changes.
Pinkstar collaborates closely with the Meirav Breast Center at Sheba Medical Center, a unique facility that provides comprehensive breast cancer care under one roof. With the Meirav Center operating one of Israel’s leading breast radiology units, the collaboration provides access to clinical expertise and high-quality data through approximately 5,000 breast MRI scans performed annually, as well as the ongoing monitoring of thousands of high-risk women.
Moving Forward Together
Sheba Medical Center remains committed to innovation and collaboration as part of its mission to advance healthcare. Through partnerships like this one, Sheba actively works with leading organizations to explore new solutions, develop emerging technologies, and apply them in ways that improve patient care.
We would also like to take this opportunity to encourage all women reading this article to remain proactive about their health and to follow recommended screening guidelines. Early detection remains a critical factor in improving outcomes and saving lives.
More Posts
A Choice at 18, a Son at 44: How Sheba Restored Kassandra’s Fertility After 23 Years
At 18, before cancer treatment that could affect her fertility, Kassandra had portions of her ovarian tissue frozen, without knowing if medical science would ever advance enough to make parenthood possible for her. More than 23 years later, Prof. Dror Meirow, Director of the Fertility Preservation Center for Cancer Patients at Sheba Medical Center, and his team performed the transplant that eventually led to the birth of Kassandra’s son.
From Pilots to Clinical Practice: The Implementation of AI at Sheba
Sheba Medical Center is expanding the use of artificial intelligence across its departments, with AI systems already in active use in everyday clinical care. Sheba has also begun deploying a platform that gives clinicians access to medical literature and protocols at the point of care, while physicians remain responsible for medical decisions.
PinkStar & Mount Sinai Partnership to Advance Breast MRI Technology
A medical imaging startup first incubated within Sheba’s innovation ecosystem, PinkStar has entered an agreement with Mount Sinai Health System set to advance breast MRI protocols and support early cancer detection. The partnership marks PinkStar’s first collaboration with a U.S. academic medical institution.
